CL

COLGATE PALMOLIVE CO

Consumer Defensive | Large Cap

$0.96

EPS Forecast

$5,346

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Colgate’s Q3 2024 Earnings Shine Quietly: CL Delivers Margins and Momentum, Puts Guidance Back on the Shelf

Ticker: CL. Key metrics include EPS of $0.90, solid revenue forecast updates, and a first glance at earnings surprise dynamics in a steady consumer-staples backdrop. The firm reports revenue resilience and margin expansion as it updates full-year expectations.

Q3 2024 Highlights

  • Net Sales: $5,033 million for the third quarter, up 2.4% versus the prior year.
  • Organic Sales growth: 6.8% year over year, underscoring price/mix strength alongside volume modestly contributing.
  • EPS (diluted): $0.90 for the quarter, up 5% from $0.86 in the prior year; Base Business EPS up 6% to $0.91.
  • Profitability: GAAP gross margin up 260 basis points to 61.1%; Base Business gross margin up 270 basis points to 61.3%.
  • Cash Flow: Net cash provided by operations was $2,838 million for the first nine months of 2024.
  • Market Position: Global toothpaste market share at 41.6% year to date; manual toothbrushes at 32.3% year to date.
  • Guidance: The company updated its full-year 2024 financial guidance, signaling continued confidence in the underlying business trajectory.

What the figures suggest (and what they don’t)

The quarterly print isn’t a “blowout,” but it’s a clean ledger with some durable assets showing through: a solid organic growth rate, margin expansion, and a cash-generative engine that doesn’t depend on heavy capex or debt. The EPS beat is modest but real, and the strong gross margin expansion implies favorable product mix and disciplined cost management—an especially welcome tune in a year where input costs can swing like a pendulum.

On a headline level, Colgate’s numbers reinforce a stability story rather than a growth story. The earnings surprise angle remains subtle—the press release presents solid results but does not hinge on an explicit deviation from consensus, at least in the material released here. The reference to a refreshed revenue forecast through full-year 2024 points to management comfort with ongoing demand and pricing power in core categories.

The operating cash flow figure is notable. Nearly $2.84 billion in the first nine months signals that the business remains remarkably cash-friendly, which matters for capital allocation, dividends, and potential buybacks. In an environment where some peers are recalibrating growth bets, Colgate’s cash generation acts like a whitening strip for the income statement: it clears up the underlying profitability and leaves little room for mischief in the margins.

Market positions in toothpaste and toothbrushes are meaningful indicators of brand strength in essential categories. A 41.6% global toothpaste share points to pricing power and category leadership—factors that matter when inflation or promotional intensity pressure consumer staples margins. It’s not a bet on a new smartwatch, but on the durable habit of brushing twice a day and buying consistently.

Guidance and what it portends for the year

The update to Colgate’s financial guidance for 2024 is the most telling line in the release. It signals management’s confidence that the trajectory observed in the first three quarters can be sustained or modestly improved. In practical terms, this can translate into a higher revenue forecast or at least a steadier path toward mid-teens-ish margins, depending on how the mix evolves and how market conditions unfold across regions.

From a capital-allocation lens, a refreshed outlook often implies potential for continued buybacks or dividend support—especially for a consumer-staples franchise where visibility and predictability are valued by investors. It also puts a bead on the EPS consensus conversation: if the street had been counting on more acceleration, a guided-up path helps align expectations and reduces the risk of a surprise in the wrong direction during the next quarterly update.

Implications for CL and sector peers

Colgate’s quarter reinforces a broader theme in consumer staples: resilience via pricing power and brand loyalty, rather than dramatic volume surges. For peers in oral care and broader household products, the message is twofold. First, a steady, margin-friendly growth profile remains highly valued in a market where demand can be volatile. Second, a credible, dividend-friendly cash-flow story matters as much as any single product cycle.

If Colgate sustains its organic growth momentum and margin expansion into year-end, expectations for sector peers might tilt toward stronger pricing discipline and more selective investments in product innovation and distribution. The “earnings surprise” risk, historically moderate for this space, could hinge on how well others translate brand strength into price realization without eroding demand in a crowded marketplace.

Takeaway: durability over drama

Colgate’s Q3 2024 results read like a well-kept ledger: disciplined growth, margin expansion, and robust cash generation, backed by brand leadership in core categories. The EPS of $0.90 and the refreshed revenue forecast for the year create a narrative of durable profitability rather than a flash-in-the-pan rally. For CL and its sector peers, the question isn’t whether the toothpaste will alphabet-soup into higher highs, but whether the toothpaste will stay ahead of inflation and channel shifts long enough to justify a higher multiple.

As always, the real story emerges when the company hosts its earnings call—where the EPS consensus commentary and any incremental guidance details flow in. For now, Colgate provides a reliable, if unflashy, refinement of a classic brand-powered growth story.